glp-1 long term risks GLP‑1 Long‑Term Safety: Side Effects You Should Know The Evolution of GLP-1 Users
Description
Losing weight too quickly without enough protein, hydration, resistance training, or monitoring can create other problems
In large-scale studies, semaglutide (the active ingredient in Ozempic and Wegovy) led to an average placebo-corrected weight loss of about 12.4% at the 2.4 mg dose
Primary Care, 49 (4), 517-530
Internationally, Lilly has been more aggressive than some peers in signing distribution and co-promotion deals
If you're ready to get started on a path that includes this level of comprehensive support, you can Start Your Treatment Now
